BORTEZOMIB TEVA 2.5 MG

Krajina: Izrael

Jazyk: angličtina

Zdroj: Ministry of Health

Aktívna zložka:

BORTEZOMIB

Dostupné z:

ABIC MARKETING LTD, ISRAEL

ATC kód:

L01XX32

Forma lieku:

POWDER FOR SOLUTION FOR INJECTION

Zloženie:

BORTEZOMIB 2.5 MG

Spôsob podávania:

I.V

Typ predpisu:

Required

Výrobca:

TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY

Terapeutické oblasti:

BORTEZOMIB

Terapeutické indikácie:

Bortezomib Teva is indicated for the treatment of patients with multiple myeloma. Bortezomib Teva is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. Bortezomib Teva in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation

Dátum Autorizácia:

2017-07-04